Wellington Management Group
NBRV

Wellington Management Group’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Wellington Management Group’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-14,378
Closed -$5.25M – 2162
2018
Q4 		$5.25M Sell
14,378
-5,561
-28% -$2.99M ﹤0.01% 1369
2018
Q3 		$13.5M Sell
19,939
-415
-2% -$294K ﹤0.01% 1198
2018
Q2 		$17.7M Sell
20,354
-207
-1% -$237K ﹤0.01% 1118
2018
Q1 		$25.9M Buy
20,561
+13,606
+196% +$20.1M 0.01% 992
2017
Q4 		$10.4M Sell
6,955
-477
-6% -$754K ﹤0.01% 1261
2017
Q3 		$15.2M Sell
7,432
-1,177
-14% -$2.76M ﹤0.01% 1161
2017
Q2 		$24.2M Sell
8,609
-8
-0.1% -$20.6K 0.01% 965
2017
Q1 		$25.8M Buy
8,617
+776
+10% +$1.89M 0.01% 942
2016
Q4 		$11.7M Sell
7,841
-89
-1% -$118K ﹤0.01% 1152
2016
Q3 		$14.1M Sell
7,930
-459
-5% -$885K ﹤0.01% 1077
2016
Q2 		$15.7M Sell
8,389
-1,035
-11% -$2.09M ﹤0.01% 1026
2016
Q1 		$21.1M Sell
9,424
-92
-1% -$198K 0.01% 911
2015
Q4 		$22.7M Buy
9,516
+1,205
+14% +$2.94M 0.01% 924
2015
Q3 		$19.7M Buy
+8,311
New +$22M 0.01% 974

Other funds holding NBRV

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Wellington Management Group's NBRV Position: Q1 2019 in Review

Wellington Management Group sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q1 2019, closing a stake of 14,378 shares — an estimated $5.25M sold.

Wellington Management Group first reported a position in NBRV in Q3 2015 and held it in 14 quarters. The position peaked at $25.9M in Q1 2018. 39 funds tracked by Wall St. Rank hold NBRV as of Q1 2019.

  • Wellington Management Group reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q1 2019 after selling out during the quarter.
  • Wellington Management Group sold 14,378 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q1 2019, an estimated $5.25M.
  • Wellington Management Group first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2015 and held it in 14 quarters.
  • Wellington Management Group's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $25.9M in Q1 2018.
  • 39 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q1 2019.

Based on Wellington Management Group's 13F filing for Q1 2019, filed 15 May 2019.